Axon's Software & Services Strength in Focus: More Upside Ahead?

Axon's Software & Services revenue rose 39.6% YoY in 2025, driven by digital evidence management and premium subscriptions, supporting rising ARR. The company issued bullish 2026 revenue guidance of ~27–30% YoY growth and expects stronger CUAS demand for its Dedrone platform from NATO and other agencies. Shares have outperformed, up 14.8% over the past month, while the stock trades at a forward P/E of 58.5x versus the industry 45.9x and Zacks' consensus 2026 EPS estimate has increased 4.8% in the past 60 days.

Analysis

Axon’s trajectory looks less like a one-off product cycle and more like a SaaS flywheel entering a higher-LTV phase: rising attach rates for premium features should compress CAC payback and push incremental revenue straight to high-margin ARR within 12–24 months. That dynamic magnifies upside to free cash flow more than headline revenue growth implies because software renewals and add-ons are low-capex and scale with minimal incremental variable cost.

The defense/CUAS angle introduces a lumpy, multi-year revenue stream with different margin and cash timing characteristics than municipal policing contracts. Procurement for NATO and allied airspace projects will be cadence-driven (award → fielding → sustainment over 12–36 months), benefiting sensor and subsystem suppliers upstream while also creating contingent liabilities around certification, export controls, and integration-related support costs.

Valuation is pricing multi-year execution and an expansion of ARR multiples; that makes the name a binary beat/miss into guidance seasons and contract announcements. Key near-term catalysts are ARR growth inflection, churn signals in subscription cohorts, and any large public-sector contract awards; conversely, budget reprioritization, data-privacy litigation, or export/regulatory friction could unwind sentiment quickly over a 1–6 month window.

Key Decisions for Investors

• Pair trade (6–12 months): Long AXON equity 3–5% portfolio weight, hedge 50% notional by shorting TDY to neutralize hardware/sensor-cycle risk. R/R: asymmetric — aim for ~+30% on AXON vs ~-10% on TDY; stop-loss: reduce long if AXON drops 20% or if churn cohort metrics deteriorate.
• Options spread (12 months): Buy AXON 12-month OTM call spread (buy nearer-OTM, sell 1.5x strike) sized to 1–2% portfolio risk. Rationale: captures multi-quarter ARR acceleration with defined downside (premium) and 3–5x upside if guidance execution and a major defense award materialize.
• Credit/flow hedge (3–9 months): Buy protection via AXON short-dated puts (sell covered calls if you own equity) around major milestones (quarterly guidance, contract award windows). Rationale: limits tail risk from procurement delays or multiple compression during event windows; cost can be financed by selling short-dated calls for income.
• Hardware exposure (6–18 months): Small long in TDY or WWD (2–3% each) to play higher demand for imaging/subsystems from CUAS and allied defense buys. R/R: lower multiple but steadier cash conversion; exit or trim if order backlog revisions miss or supply-chain inflation materially increases COGS.